COO - MedTech Stock Cooper Companies Poised For Organic Growth Analysts Have Confidence In Stock | Benzinga
Wednesday, Cooper Companies (NYSE: COO) reported Q3 adjusted EPS of $3.35, slightly ahead of the consensus Of $3.34.
The company reported Q3 sales of $930.20 million, up 10% Y/Y, up 11% in constant currency, up 12% organically, beating the consensus of $899.75 million.
The company sees FY24 adjusted EPS of $12.72-$12.90 compared to the consensus of $12.82.
It sees revenue of $3.578-$3.595 billion versus the consensus of $3.55 billion.
After yet another robust quarter in revenue, William ...